Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 25, 2021

SELL
$157.07 - $174.35 $208,588 - $231,536
-1,328 Closed
0 $0
Q3 2020

Oct 22, 2020

BUY
$137.1 - $165.37 $182,068 - $219,611
1,328 New
1,328 $220,000
Q2 2020

Jul 21, 2020

SELL
$111.92 - $142.53 $8.02 Million - $10.2 Million
-71,662 Closed
0 $0
Q1 2020

Apr 28, 2020

BUY
$92.66 - $144.94 $748,692 - $1.17 Million
8,080 Added 12.71%
71,662 $8.43 Million
Q4 2019

Feb 10, 2020

BUY
$116.25 - $133.25 $6,975 - $7,995
60 Added 0.09%
63,582 $8.42 Million
Q3 2019

Oct 24, 2019

SELL
$112.57 - $128.43 $2.62 Million - $2.99 Million
-23,263 Reduced 26.81%
63,522 $7.91 Million
Q2 2019

Aug 07, 2019

BUY
$97.98 - $114.28 $5,682 - $6,628
58 Added 0.07%
86,785 $9.85 Million
Q1 2019

May 10, 2019

BUY
$81.56 - $100.67 $7.07 Million - $8.73 Million
86,727 New
86,727 $8.73 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Vantage Investment Partners, LLC Portfolio

Follow Vantage Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vantage Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vantage Investment Partners, LLC with notifications on news.